Duloxetine and pregabalin: High-dose monotherapy or their combination? The “COMBO-DN study” – a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain

[1]  G. Hui,et al.  Diagnosis and management of neuropathic pain. , 2014, Pain management.

[2]  T. Toelle,et al.  Pregabalin in Neuropathic Pain Related to DPN, Cancer and Back Pain:Analysis of a 6-Week Observational Study , 2012 .

[3]  D. Selvarajah,et al.  Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy , 2012, Diabetes/metabolism research and reviews.

[4]  A. Vinik,et al.  Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management , 2011, Diabetes/metabolism research and reviews.

[5]  V. Skljarevski,et al.  Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison. , 2011, Mayo Clinic proceedings.

[6]  J. Dostrovsky,et al.  Assessing symptom profiles in neuropathic pain clinical trials: Can it improve outcome? , 2011, European journal of pain.

[7]  A. Vinik.  The approach to the management of the patient with neuropathic pain. , 2010, The Journal of clinical endocrinology and metabolism.

[8]  T. Jensen,et al.  The evidence for pharmacological treatment of neuropathic pain , 2010, PAIN.

[9]  T. Nurmikko,et al.  EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision , 2010, European journal of neurology.

[10]  D. Tu,et al.  Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial , 2009, The Lancet.

[11]  R. Dworkin,et al.  Treatment of neuropathic pain: an overview of recent guidelines. , 2009, The American journal of medicine.

[12]  P. Wiffen,et al.  Pregabalin for acute and chronic pain in adults. , 2009, The Cochrane database of systematic reviews.

[13]  J. Deijen,et al.  Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series , 2009, BMC neurology.

[14]  M. Hanna,et al.  Prolonged‐release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients , 2008, European journal of pain.

[15]  S. Donevan,et al.  Ca2+ channel α2δ ligands: novel modulators of neurotransmission , 2007 .

[16]  B. Mccarberg,et al.  Duloxetine for the management of diabetic peripheral neuropathic pain: response profile. , 2006, Pain medicine.

[17]  Ali Moghtaderi,et al.  Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy , 2006, Clinical Neurology and Neurosurgery.

[18]  B. Stacey,et al.  Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. , 2005, Journal of pain and symptom management.

[19]  E. Whalen,et al.  Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens , 2005, Pain.

[20]  S. Iyengar,et al.  Efficacy of Duloxetine, a Potent and Balanced Serotonin-Norepinephrine Reuptake Inhibitor in Persistent Pain Models in Rats , 2004, Journal of Pharmacology and Experimental Therapeutics.

[21]  Jacques Fermanian,et al.  Development and validation of the Neuropathic Pain Symptom Inventory , 2004, Pain.

[22]  D. A. Simpson.  Gabapentin and Venlafaxine for the Treatment of Painful Diabetic Neuropathy , 2001, Journal of clinical neuromuscular disease.

[23]  C. Cleeland,et al.  Pain assessment: global use of the Brief Pain Inventory. , 1994, Annals of the Academy of Medicine, Singapore.

[24]  Huston Gj,et al.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[25]  G. Nahler.  European Public Assessment Report (EPAR) , 2009 .

[26]  R. Freeman,et al.  Efficacy, safety and tolerability of pregabalin treatment of painful diabetic peripheral neuropathy: findings from 7 randomized, controlled trials across a range of doses , 2008 .

[27]  S. Donevan,et al.  Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission. , 2007, Trends in pharmacological sciences.

[28]  D. Selvarajah,et al.  Morphine, gabapentin, or their combination for neuropathic pain. , 2005, The New England journal of medicine.